Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats
1 Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2 Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark Submitted 9 April 2007 ; accepted in final form 6 February 2008 Luminal nutrients stimulate structural and...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2008-04, Vol.294 (4), p.R1175-R1184 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | R1184 |
---|---|
container_issue | 4 |
container_start_page | R1175 |
container_title | American journal of physiology. Regulatory, integrative and comparative physiology |
container_volume | 294 |
creator | Nelson, David W Murali, Sangita G Liu, Xiaowen Koopmann, Matthew C Holst, Jens J Ney, Denise M |
description | 1 Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2 Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark
Submitted 9 April 2007
; accepted in final form 6 February 2008
Luminal nutrients stimulate structural and functional regeneration in the intestine through mechanisms thought to involve insulin-like growth factor I (IGF-I) and glucagon-like peptide-2 (GLP-2). We investigated the relationship between IGF-I and GLP-2 responses and mucosal growth in rats fasted for 48 h and then refed for 2 or 4 days by continuous intravenous or intragastric infusion or ad libitum feeding. Fasting induced significant decreases in body weight, plasma concentrations of IGF-I and bioactive GLP-2, jejunal mucosal cellularity (mass, protein, DNA, and villus height), IGF-I mRNA, and ileal proglucagon mRNA. Plasma IGF-I concentration was restored to fed levels with 2 days of ad libitum refeeding but not with 4 days of intravenous or intragastric refeeding. Administration of an inhibitor of endogenous GLP-2 (rat GLP-2 3–33 ) during ad libitum refeeding partially attenuated mucosal growth and prevented the increase in plasma IGF-I to fed levels; however, plasma GLP-2 and jejunal IGF-I mRNA were restored to fed levels. Intragastric refeeding restored intestinal cellularity and functional capacity (sucrase activity and sodium-glucose transporter-1 expression) to fed levels, whereas intravenous refeeding had no effect. Intestinal regeneration after 4 days of intragastric or 2 days of ad libitum refeeding was positively associated with increases in plasma concentrations of GLP-2 and jejunal IGF-I mRNA. These data suggest that luminal nutrients stimulate intestinal growth, in part, by increased expression of both GLP-2 and IGF-I.
parenteral nutrition; proglucagon; sodium-glucose linked transporter-1; GLP-2 3–33
Address for reprint requests and other correspondence: D. M. Ney, Univ. of Wisconsin-Madison, Dept. of Nutritional Sciences, 1415 Linden Dr., Madison, WI 53706 (e-mail: ney{at}nutrisci.wisc.edu ) |
doi_str_mv | 10.1152/ajpregu.00238.2007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_229729573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1462238211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-99179a004840c5cde71bf364a53096c75a9be2f4a2b127a34dc6441373fb574e3</originalsourceid><addsrcrecordid>eNp1kE-PEyEYh4nRuN3VL-DBEO9T-TsUb2bjapNNTMx6JgwwUyodRmBSe_eDS-1s1osn8obn-fHyA-ANRmuMOXmv91Nyw7xGiNDNmiAknoFVvSANZhI9BytEW9q0GMsrcJ3zHiHEKKMvwRXeEN5iylfg93bMc_BjE_wPB4cUj2UHe21KTHAL9WjhEGajh7gQk5uKt64hMLk8xTG7DEusRi5-HGAfQ4hHZ2F3giaOJdW5TjVMWxh858t8qGbvnD3jfoRJl_wKvOh1yO71ct6A73efHm6_NPdfP29vP943hm1YaaTEQur6iQ1DhhvrBO562jLNKZKtEVzLzpGeadJhIjRl1rSMYSpo33HBHL0B7y65U4o_Z5eL2sc5jfVJRYgURHJBK0QukEkx57qrmpI_6HRSGKlz72rpXf3tXZ17r9LbJXnuDs4-KUvRFfhwAXZ-2B19cmranbKPIQ4ndTeH8OB-lcdkIpli6hvGgqvJ9lVe_19-3OYfif4Bqhqm8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229729573</pqid></control><display><type>article</type><title>Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Nelson, David W ; Murali, Sangita G ; Liu, Xiaowen ; Koopmann, Matthew C ; Holst, Jens J ; Ney, Denise M</creator><creatorcontrib>Nelson, David W ; Murali, Sangita G ; Liu, Xiaowen ; Koopmann, Matthew C ; Holst, Jens J ; Ney, Denise M</creatorcontrib><description>1 Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2 Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark
Submitted 9 April 2007
; accepted in final form 6 February 2008
Luminal nutrients stimulate structural and functional regeneration in the intestine through mechanisms thought to involve insulin-like growth factor I (IGF-I) and glucagon-like peptide-2 (GLP-2). We investigated the relationship between IGF-I and GLP-2 responses and mucosal growth in rats fasted for 48 h and then refed for 2 or 4 days by continuous intravenous or intragastric infusion or ad libitum feeding. Fasting induced significant decreases in body weight, plasma concentrations of IGF-I and bioactive GLP-2, jejunal mucosal cellularity (mass, protein, DNA, and villus height), IGF-I mRNA, and ileal proglucagon mRNA. Plasma IGF-I concentration was restored to fed levels with 2 days of ad libitum refeeding but not with 4 days of intravenous or intragastric refeeding. Administration of an inhibitor of endogenous GLP-2 (rat GLP-2 3–33 ) during ad libitum refeeding partially attenuated mucosal growth and prevented the increase in plasma IGF-I to fed levels; however, plasma GLP-2 and jejunal IGF-I mRNA were restored to fed levels. Intragastric refeeding restored intestinal cellularity and functional capacity (sucrase activity and sodium-glucose transporter-1 expression) to fed levels, whereas intravenous refeeding had no effect. Intestinal regeneration after 4 days of intragastric or 2 days of ad libitum refeeding was positively associated with increases in plasma concentrations of GLP-2 and jejunal IGF-I mRNA. These data suggest that luminal nutrients stimulate intestinal growth, in part, by increased expression of both GLP-2 and IGF-I.
parenteral nutrition; proglucagon; sodium-glucose linked transporter-1; GLP-2 3–33
Address for reprint requests and other correspondence: D. M. Ney, Univ. of Wisconsin-Madison, Dept. of Nutritional Sciences, 1415 Linden Dr., Madison, WI 53706 (e-mail: ney{at}nutrisci.wisc.edu )</description><identifier>ISSN: 0363-6119</identifier><identifier>EISSN: 1522-1490</identifier><identifier>DOI: 10.1152/ajpregu.00238.2007</identifier><identifier>PMID: 18256135</identifier><identifier>CODEN: AJPRDO</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Adaptation, Physiological ; Animals ; Body Weight ; Dose-Response Relationship, Drug ; Eating ; Fasting - blood ; Glucagon-Like Peptide 2 - antagonists & inhibitors ; Glucagon-Like Peptide 2 - blood ; Glucagon-Like Peptide 2 - metabolism ; Glucagon-Like Peptide 2 - pharmacology ; Glucose ; Ileum - drug effects ; Ileum - growth & development ; Ileum - metabolism ; Infusions, Intravenous ; Insulin ; Insulin - blood ; Insulin-Like Growth Factor Binding Protein 3 - metabolism ; Insulin-Like Growth Factor Binding Protein 5 - metabolism ; Insulin-Like Growth Factor I - genetics ; Insulin-Like Growth Factor I - metabolism ; Intestinal Mucosa - growth & development ; Intestinal Mucosa - metabolism ; Intubation, Gastrointestinal ; Jejunum - drug effects ; Jejunum - enzymology ; Jejunum - growth & development ; Jejunum - metabolism ; Male ; Nitrogen - metabolism ; Parenteral Nutrition ; Peptide Fragments - pharmacology ; Peptides ; Plasma ; Proglucagon - metabolism ; Rats ; Rats, Sprague-Dawley ; Regeneration ; Ribonucleic acid ; RNA ; RNA, Messenger - metabolism ; Rodents ; Sodium-Glucose Transporter 1 - metabolism ; Sucrase - metabolism ; Time Factors</subject><ispartof>American journal of physiology. Regulatory, integrative and comparative physiology, 2008-04, Vol.294 (4), p.R1175-R1184</ispartof><rights>Copyright American Physiological Society Apr 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-99179a004840c5cde71bf364a53096c75a9be2f4a2b127a34dc6441373fb574e3</citedby><cites>FETCH-LOGICAL-c484t-99179a004840c5cde71bf364a53096c75a9be2f4a2b127a34dc6441373fb574e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3026,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18256135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nelson, David W</creatorcontrib><creatorcontrib>Murali, Sangita G</creatorcontrib><creatorcontrib>Liu, Xiaowen</creatorcontrib><creatorcontrib>Koopmann, Matthew C</creatorcontrib><creatorcontrib>Holst, Jens J</creatorcontrib><creatorcontrib>Ney, Denise M</creatorcontrib><title>Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats</title><title>American journal of physiology. Regulatory, integrative and comparative physiology</title><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><description>1 Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2 Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark
Submitted 9 April 2007
; accepted in final form 6 February 2008
Luminal nutrients stimulate structural and functional regeneration in the intestine through mechanisms thought to involve insulin-like growth factor I (IGF-I) and glucagon-like peptide-2 (GLP-2). We investigated the relationship between IGF-I and GLP-2 responses and mucosal growth in rats fasted for 48 h and then refed for 2 or 4 days by continuous intravenous or intragastric infusion or ad libitum feeding. Fasting induced significant decreases in body weight, plasma concentrations of IGF-I and bioactive GLP-2, jejunal mucosal cellularity (mass, protein, DNA, and villus height), IGF-I mRNA, and ileal proglucagon mRNA. Plasma IGF-I concentration was restored to fed levels with 2 days of ad libitum refeeding but not with 4 days of intravenous or intragastric refeeding. Administration of an inhibitor of endogenous GLP-2 (rat GLP-2 3–33 ) during ad libitum refeeding partially attenuated mucosal growth and prevented the increase in plasma IGF-I to fed levels; however, plasma GLP-2 and jejunal IGF-I mRNA were restored to fed levels. Intragastric refeeding restored intestinal cellularity and functional capacity (sucrase activity and sodium-glucose transporter-1 expression) to fed levels, whereas intravenous refeeding had no effect. Intestinal regeneration after 4 days of intragastric or 2 days of ad libitum refeeding was positively associated with increases in plasma concentrations of GLP-2 and jejunal IGF-I mRNA. These data suggest that luminal nutrients stimulate intestinal growth, in part, by increased expression of both GLP-2 and IGF-I.
parenteral nutrition; proglucagon; sodium-glucose linked transporter-1; GLP-2 3–33
Address for reprint requests and other correspondence: D. M. Ney, Univ. of Wisconsin-Madison, Dept. of Nutritional Sciences, 1415 Linden Dr., Madison, WI 53706 (e-mail: ney{at}nutrisci.wisc.edu )</description><subject>Adaptation, Physiological</subject><subject>Animals</subject><subject>Body Weight</subject><subject>Dose-Response Relationship, Drug</subject><subject>Eating</subject><subject>Fasting - blood</subject><subject>Glucagon-Like Peptide 2 - antagonists & inhibitors</subject><subject>Glucagon-Like Peptide 2 - blood</subject><subject>Glucagon-Like Peptide 2 - metabolism</subject><subject>Glucagon-Like Peptide 2 - pharmacology</subject><subject>Glucose</subject><subject>Ileum - drug effects</subject><subject>Ileum - growth & development</subject><subject>Ileum - metabolism</subject><subject>Infusions, Intravenous</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Insulin-Like Growth Factor Binding Protein 3 - metabolism</subject><subject>Insulin-Like Growth Factor Binding Protein 5 - metabolism</subject><subject>Insulin-Like Growth Factor I - genetics</subject><subject>Insulin-Like Growth Factor I - metabolism</subject><subject>Intestinal Mucosa - growth & development</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Intubation, Gastrointestinal</subject><subject>Jejunum - drug effects</subject><subject>Jejunum - enzymology</subject><subject>Jejunum - growth & development</subject><subject>Jejunum - metabolism</subject><subject>Male</subject><subject>Nitrogen - metabolism</subject><subject>Parenteral Nutrition</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides</subject><subject>Plasma</subject><subject>Proglucagon - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Regeneration</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA, Messenger - metabolism</subject><subject>Rodents</subject><subject>Sodium-Glucose Transporter 1 - metabolism</subject><subject>Sucrase - metabolism</subject><subject>Time Factors</subject><issn>0363-6119</issn><issn>1522-1490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE-PEyEYh4nRuN3VL-DBEO9T-TsUb2bjapNNTMx6JgwwUyodRmBSe_eDS-1s1osn8obn-fHyA-ANRmuMOXmv91Nyw7xGiNDNmiAknoFVvSANZhI9BytEW9q0GMsrcJ3zHiHEKKMvwRXeEN5iylfg93bMc_BjE_wPB4cUj2UHe21KTHAL9WjhEGajh7gQk5uKt64hMLk8xTG7DEusRi5-HGAfQ4hHZ2F3giaOJdW5TjVMWxh858t8qGbvnD3jfoRJl_wKvOh1yO71ct6A73efHm6_NPdfP29vP943hm1YaaTEQur6iQ1DhhvrBO562jLNKZKtEVzLzpGeadJhIjRl1rSMYSpo33HBHL0B7y65U4o_Z5eL2sc5jfVJRYgURHJBK0QukEkx57qrmpI_6HRSGKlz72rpXf3tXZ17r9LbJXnuDs4-KUvRFfhwAXZ-2B19cmranbKPIQ4ndTeH8OB-lcdkIpli6hvGgqvJ9lVe_19-3OYfif4Bqhqm8w</recordid><startdate>20080401</startdate><enddate>20080401</enddate><creator>Nelson, David W</creator><creator>Murali, Sangita G</creator><creator>Liu, Xiaowen</creator><creator>Koopmann, Matthew C</creator><creator>Holst, Jens J</creator><creator>Ney, Denise M</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20080401</creationdate><title>Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats</title><author>Nelson, David W ; Murali, Sangita G ; Liu, Xiaowen ; Koopmann, Matthew C ; Holst, Jens J ; Ney, Denise M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-99179a004840c5cde71bf364a53096c75a9be2f4a2b127a34dc6441373fb574e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adaptation, Physiological</topic><topic>Animals</topic><topic>Body Weight</topic><topic>Dose-Response Relationship, Drug</topic><topic>Eating</topic><topic>Fasting - blood</topic><topic>Glucagon-Like Peptide 2 - antagonists & inhibitors</topic><topic>Glucagon-Like Peptide 2 - blood</topic><topic>Glucagon-Like Peptide 2 - metabolism</topic><topic>Glucagon-Like Peptide 2 - pharmacology</topic><topic>Glucose</topic><topic>Ileum - drug effects</topic><topic>Ileum - growth & development</topic><topic>Ileum - metabolism</topic><topic>Infusions, Intravenous</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Insulin-Like Growth Factor Binding Protein 3 - metabolism</topic><topic>Insulin-Like Growth Factor Binding Protein 5 - metabolism</topic><topic>Insulin-Like Growth Factor I - genetics</topic><topic>Insulin-Like Growth Factor I - metabolism</topic><topic>Intestinal Mucosa - growth & development</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Intubation, Gastrointestinal</topic><topic>Jejunum - drug effects</topic><topic>Jejunum - enzymology</topic><topic>Jejunum - growth & development</topic><topic>Jejunum - metabolism</topic><topic>Male</topic><topic>Nitrogen - metabolism</topic><topic>Parenteral Nutrition</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides</topic><topic>Plasma</topic><topic>Proglucagon - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Regeneration</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA, Messenger - metabolism</topic><topic>Rodents</topic><topic>Sodium-Glucose Transporter 1 - metabolism</topic><topic>Sucrase - metabolism</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nelson, David W</creatorcontrib><creatorcontrib>Murali, Sangita G</creatorcontrib><creatorcontrib>Liu, Xiaowen</creatorcontrib><creatorcontrib>Koopmann, Matthew C</creatorcontrib><creatorcontrib>Holst, Jens J</creatorcontrib><creatorcontrib>Ney, Denise M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nelson, David W</au><au>Murali, Sangita G</au><au>Liu, Xiaowen</au><au>Koopmann, Matthew C</au><au>Holst, Jens J</au><au>Ney, Denise M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats</atitle><jtitle>American journal of physiology. Regulatory, integrative and comparative physiology</jtitle><addtitle>Am J Physiol Regul Integr Comp Physiol</addtitle><date>2008-04-01</date><risdate>2008</risdate><volume>294</volume><issue>4</issue><spage>R1175</spage><epage>R1184</epage><pages>R1175-R1184</pages><issn>0363-6119</issn><eissn>1522-1490</eissn><coden>AJPRDO</coden><abstract>1 Department of Nutritional Sciences, University of Wisconsin-Madison, Madison, Wisconsin; and 2 Department of Medical Physiology, Panum Institute, University of Copenhagen, Copenhagen, Denmark
Submitted 9 April 2007
; accepted in final form 6 February 2008
Luminal nutrients stimulate structural and functional regeneration in the intestine through mechanisms thought to involve insulin-like growth factor I (IGF-I) and glucagon-like peptide-2 (GLP-2). We investigated the relationship between IGF-I and GLP-2 responses and mucosal growth in rats fasted for 48 h and then refed for 2 or 4 days by continuous intravenous or intragastric infusion or ad libitum feeding. Fasting induced significant decreases in body weight, plasma concentrations of IGF-I and bioactive GLP-2, jejunal mucosal cellularity (mass, protein, DNA, and villus height), IGF-I mRNA, and ileal proglucagon mRNA. Plasma IGF-I concentration was restored to fed levels with 2 days of ad libitum refeeding but not with 4 days of intravenous or intragastric refeeding. Administration of an inhibitor of endogenous GLP-2 (rat GLP-2 3–33 ) during ad libitum refeeding partially attenuated mucosal growth and prevented the increase in plasma IGF-I to fed levels; however, plasma GLP-2 and jejunal IGF-I mRNA were restored to fed levels. Intragastric refeeding restored intestinal cellularity and functional capacity (sucrase activity and sodium-glucose transporter-1 expression) to fed levels, whereas intravenous refeeding had no effect. Intestinal regeneration after 4 days of intragastric or 2 days of ad libitum refeeding was positively associated with increases in plasma concentrations of GLP-2 and jejunal IGF-I mRNA. These data suggest that luminal nutrients stimulate intestinal growth, in part, by increased expression of both GLP-2 and IGF-I.
parenteral nutrition; proglucagon; sodium-glucose linked transporter-1; GLP-2 3–33
Address for reprint requests and other correspondence: D. M. Ney, Univ. of Wisconsin-Madison, Dept. of Nutritional Sciences, 1415 Linden Dr., Madison, WI 53706 (e-mail: ney{at}nutrisci.wisc.edu )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18256135</pmid><doi>10.1152/ajpregu.00238.2007</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6119 |
ispartof | American journal of physiology. Regulatory, integrative and comparative physiology, 2008-04, Vol.294 (4), p.R1175-R1184 |
issn | 0363-6119 1522-1490 |
language | eng |
recordid | cdi_proquest_journals_229729573 |
source | MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adaptation, Physiological Animals Body Weight Dose-Response Relationship, Drug Eating Fasting - blood Glucagon-Like Peptide 2 - antagonists & inhibitors Glucagon-Like Peptide 2 - blood Glucagon-Like Peptide 2 - metabolism Glucagon-Like Peptide 2 - pharmacology Glucose Ileum - drug effects Ileum - growth & development Ileum - metabolism Infusions, Intravenous Insulin Insulin - blood Insulin-Like Growth Factor Binding Protein 3 - metabolism Insulin-Like Growth Factor Binding Protein 5 - metabolism Insulin-Like Growth Factor I - genetics Insulin-Like Growth Factor I - metabolism Intestinal Mucosa - growth & development Intestinal Mucosa - metabolism Intubation, Gastrointestinal Jejunum - drug effects Jejunum - enzymology Jejunum - growth & development Jejunum - metabolism Male Nitrogen - metabolism Parenteral Nutrition Peptide Fragments - pharmacology Peptides Plasma Proglucagon - metabolism Rats Rats, Sprague-Dawley Regeneration Ribonucleic acid RNA RNA, Messenger - metabolism Rodents Sodium-Glucose Transporter 1 - metabolism Sucrase - metabolism Time Factors |
title | Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A33%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin-like%20growth%20factor%20I%20and%20glucagon-like%20peptide-2%20responses%20to%20fasting%20followed%20by%20controlled%20or%20ad%20libitum%20refeeding%20in%20rats&rft.jtitle=American%20journal%20of%20physiology.%20Regulatory,%20integrative%20and%20comparative%20physiology&rft.au=Nelson,%20David%20W&rft.date=2008-04-01&rft.volume=294&rft.issue=4&rft.spage=R1175&rft.epage=R1184&rft.pages=R1175-R1184&rft.issn=0363-6119&rft.eissn=1522-1490&rft.coden=AJPRDO&rft_id=info:doi/10.1152/ajpregu.00238.2007&rft_dat=%3Cproquest_cross%3E1462238211%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229729573&rft_id=info:pmid/18256135&rfr_iscdi=true |